Metformin

Dr. Andrew Huberman Explicitly Avoids for Longevity

Huberman covers metformin across 5 videos, ranging from blood glucose regulation to a dedicated Journal Club episode. In his Journal Club with Attia, they critically examine metformin studies, particularly the 2014 Banister study and a newer Danish twin study that cast doubt on metformin's survival advantage. In his longevity supplements AMA, Huberman explicitly states he avoids metformin, berberine, and rapamycin for longevity. He also discusses metformin as a glucose-lowering prescription drug in his hunger and satiety episodes, noting its potency but warning about hypoglycemia risks. A guest episode with David Sinclair touches on metformin as part of Sinclair's personal longevity protocol.

I'll just be very direct and say I do not take metformin. And I also don't take what some people call the poor man's version of metformin, which is berberine. Berberine gives me brutal headaches. Berberine lowers blood glucose. That's why I think it's giving me brutal headaches. A lot of people have explored or are thinking about exploring taking metformin or berberine for sake of lowering blood glucose and lowering a particular cellular, let's just say, pathway or a set of molecules, mTOR being the most common of them. mTOR, mammalian Target of Rapamycin, is abundant in developing cells. It's responsible for the growth of individual cells.

▶ 18:56 · AMA #12: Thoughts on Longevity Supplements (Resveratrol, NR, NMN, Etc.) & How to Improve Memory

4 more clips

• 01:27 · Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects (Guest: Peter Attia)
• 10:00 · Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects (Guest: Peter Attia)
• 26:45 · How Our Hormones Control Our Hunger, Eating & Satiety (Guest: Layne Norton)
• 24:05 · The Biology of Slowing & Reversing Aging | Dr. David Sinclair (Guest: David Sinclair)

Dr. Peter Attia Shifted from Cautious to Skeptical

Attia provides the most extensive metformin coverage of any expert, with 27+ videos spanning mechanism-of-action deep dives, clinical trial analysis, and his personal evolution on the topic. His journey is instructive: early episodes with Nir Barzilai explored the TAME trial and metformin's geroprotective potential. Episodes with Navdeep Chandel detailed metformin's mechanism as a weak inhibitor of mitochondrial complex one. However, in episode #103, Attia publicly reversed his position, concluding metformin may be a mitochondrial toxin for healthy individuals. He further explored metformin's negative impact on Zone 2 exercise performance and covered the ITP's failure to show lifespan extension in mice. In his insulin resistance masterclass with Ralph DeFronzo, Attia clarified that metformin primarily reduces hepatic glucose output and is not truly an insulin sensitizer despite common misconceptions. His longevity roundtable episode expressed continued skepticism about current evidence for metformin in humans.

…so um in my experience both personally and with other patients uh metformin categorically lowers zone two so what we notice in patients on metformin is even fasting uh pardon me even at rest so before you do the test uh your their zone their their i'm sorry their their plasma lactate or you know capillary lactate uh can easily be close to two um and why is that well um you know metformin inhibits complex one of the mitochondria among other things metformin does so many things uh that i suspect part of what it's in it what it's doing is sort of weakly poisoning the mitochondria and so when a patient's taking…

▶ 30:00 · Q&A on Zone 2 Exercise with Peter Attia, M.D.

7 more clips

• 04:49 · #103 — Looking back on the first 99 episodes: Strong Convictions, Loosely Held
• 33:45 · #31 — Navdeep Chandel, Ph.D.: metabolism, mitochondria, and metformin in health and disease (Guest: Navdeep Chandel)
• 34:04 · 204 - Centenarians, metformin, and longevity | Nir Barzilai, M.D. (Guest: Nir Barzilai)
• 01:58:36 · 281 — Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program (Guest: Richard Miller)
• 14:37 · #123 — Joan Mannick & Nir Barzilai: Rapamycin and metformin — longevity, immune enhancement, & COVID-19 (Guest: Joan Mannick)
• 00:00 · About TAME: A Metformin Anti-Aging Clinical Trial | Peter Attia, M.D. & Nir Barzilai, M.D. (Guest: Nir Barzilai)
• 10:34 · 337 — Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more (Guest: Ralph DeFronzo)

Dr. Rhonda Patrick Minimal Direct Coverage

Rhonda Patrick has minimal direct coverage of metformin. In her interview with Dr. Dominic D'Agostino about ketosis and metabolic health, metformin is briefly mentioned alongside fasting and ketogenic diets as a metabolic intervention for cancer prevention. Patrick's focus on metabolic health centers on nutrients like omega-3s, vitamin D, sulforaphane, and exercise rather than pharmaceutical longevity agents.

1 more clip

• 13:07 · Dominic D'Agostino, Ph.D. on Modified Atkins Diet, Keto-Adaptation, Ketosis & More (Guest: Dominic D'Agostino)

Bryan Johnson Uses in Blueprint Protocol

Bryan Johnson includes metformin in his Blueprint longevity protocol alongside rapamycin, as documented in his appearance on Mark Hyman's show. Johnson emphasizes the importance of blood monitoring when using these drugs and takes a data-driven approach, measuring over 200 data points daily to track their effects. However, Johnson's own YouTube channel contains no metformin-specific content in our analyzed dataset, and the details of his metformin dosing and personal results are not elaborated in the available summaries.

1 more clip

• 14:00 · The Ultimate Longevity Routine: Diet, Supplement, & Sleep Tips You Need To Know | Bryan Johnson (Guest on Mark Hyman's channel)

Dr. Mark Hyman Prefers Lifestyle Over Metformin

Hyman covers metformin across 11 videos in two distinct contexts: as a diabetes treatment and as a potential longevity agent. For diabetes, he identifies metformin as the only medication he recommends, praising its safety record and effectiveness at improving insulin sensitivity while warning against other diabetes drugs like sulfonylureas. For longevity, Hyman takes a more measured stance: he hosts Nir Barzilai discussing the TAME trial, features David Sinclair sharing his personal metformin use, and evaluates AMPK-activating compounds — but consistently concludes that lifestyle interventions (diet, exercise, fasting) outperform pharmacological approaches. He also notes that plant-based phytochemicals may offer safer alternatives to metformin's AMPK activation. In his PCOS episodes, Hyman critiques conventional medicine's reliance on metformin for symptom management rather than addressing root dietary and metabolic causes.

…biguanides especially metformin or glucophage and it's one of the best medications to improve insulin sensitivity now it's really the only medication I ever recommend for diabetes it's well tolerated it's been around for a long time it's been well studied and it helps lower blood sugar by improving your cell's response to insulin as we will see in a moment most of the other medications out there cause serious complications or actually make things worse by boosting insulin levels while they're lowering blood sugar and that increases the risk of death and heart attacks the next class of medications I want to address are the tholin diione drugs or tzds these include things like…

▶ 00:33 · Diabesity Tip 5: Why Medications Don't Fix the Problem

4 more clips

• 25:48 · REVERSE AGING: How To Prevent Chronic Disease & End Inflammation!
• 04:17 · This Doctor Thinks They Have The Longevity Protocol To Prevent Disease | Nir Barzilai (Guest: Nir Barzilai)
• 07:30 · Death is Inevitable but Aging is Not
• 30:56 · DO THIS DAILY To Increase Lifespan & REVERSE AGING! | Mark Hyman & Frank Lipman (Guest: Frank Lipman)

What do experts agree on about metformin?

Metformin is the most debated longevity drug among the 5 experts. Attia has extensively covered it across 27+ videos but shifted from cautious optimism to skepticism, concluding it may be a mitochondrial toxin for healthy individuals.

Where do the experts disagree on metformin?

Attia fundamentally shifted from cautious optimism to active skepticism about metformin for longevity in healthy individuals, while Barzilai (a frequent guest on Attia's show) continues to champion it through the TAME trial as a geroprotective agent. Huberman avoids metformin entirely for longevity, citing insufficient human data, while Johnson actively takes it as part of his Blueprint protocol based on his data-driven approach. Hyman frames metformin as the safest diabetes drug and acknowledges AMPK activation, but concludes lifestyle interventions outperform it — contrasting with Sinclair (guest on both Huberman and Hyman shows) who personally takes metformin daily as part of his anti-aging regimen.

How strong is the expert consensus on metformin?

The consensus on metformin scores 2.3/5 — a split level of agreement across Huberman, Attia, Patrick, Johnson, and Hyman, based on their public videos.